Affiliation:
1. Department of Medical Laboratory Technology, Health Polytechnic of Ministry of Health Jambi, Jambi, Indonesi
2. Nursing Department, Health Polytechnic of Ministry of Health Jambi, Jambi, Indonesia
Abstract
Coronavirus Disease-2019 (COVID-19) belongs to the large family of SARS-CoV viruses, initially emerging
in 2002-2003. In humans, this virus triggers respiratory infectious diseases. COVID-19, a new variant of
SARS-CoV, was identified in humans following an unprecedented incident in Wuhan, China, in December
2019. This virus typically manifests mild symptoms, including a runny nose, sore throat, cough, and fever.
The Nucleic Acid Amplification Test (NAAT), specifically the realtime Reverse Transcription Polymerase
Chain Reaction (rRT-PCR) examination, is recommended by the World Health Organization (WHO) for diagnosing COVID-19. This study assessed potential differences in Threshold Cycle results during RNA extraction using magnetic beads compared to spin columns in the SARS-CoV-2 rRT-PCR method. The population for this study was selected through accidental sampling from nasopharyngeal and oropharyngeal swabs
of COVID-19 patients obtained between December 2022 and April 2023, with Threshold Cycle values
<30,000. The samples were stored at -80°C. The findings revealed that the average N (VIC) was 23.359, and
RdRP (FAM) was 25.558 in the Magnetic Beads method, indicating a lower value compared to the average N
(VIC) of 29.200 and RdRP (FAM) of 29.661 in the Spin Column method. This suggests that the Magnetic
Beads method exhibited greater sensitivity than the Spin Column method. The statistical analysis confirmed
these differences, with a P value of 0.003 in N (VIC) and the P value of 0.000 in RdRP (FAM). Consequently,
it can be concluded that there is a significant 19.5% difference in the Threshold Cycle during RNA extraction
using Magnetic Beads and Spin Column in the examination of the SARS-CoV-2 rRT-PCR method.
Keywords: Sars-CoV-2; rRT-PCR; Magnetic Beads; Spin Column; Threshold Cycle.
Reference71 articles.
1. 1. Hu B, Guo H, Zhou P, Shi Z-L. Characteristics of SARS-CoV-2 and COVID-19. Nature Reviews Microbiology. 2021;19(3):141–54.
2. 2. Kumar S, Nyodu R, Maurya VK, Saxena SK. Host immune response and immunobiology of human
3. SARS-CoV-2 infection. Coronavirus Disease 2019 (COVID-19) Epidemiology, Pathogenesis, Diagnosis, and Therapeutics. 2020;43–53.
4. 3. WHO U, UNDP FAO. COVID-19 UPDATE. WHO Switzerland; 2022.
5. 4. Zhang WS, Pan J, Li F, Zhu M, Xu M, and H et al. Reverse transcription recombinase polymerase